Overview

The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study in patients with stable schizophrenia will investigate the effect of JNJ-39393406 on Event Related Potentials (Auditory Evoked Potential [AEP] P50, AEP P300 and Mismatch Negativity [MMN]) after single dose administration.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Pharmaceutica N.V., Belgium